drugset / Trial / NCT00819845
Ramipril Versus Carvedilol in Duchenne and Becker Patients
RandomizedParallel-groupOpen-labelPrevention
Summary
Data on preventive therapy in Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) affected individuals without cardiac involvement are very limited and currently lacking regard both ACE-inhibitors and Beta-Blockers in Becker Muscular Dystrophy and for the latter even in Duchenne Muscular Dystrophy patients. Thus, the study aim is to compare the efficacy of carvedilol vs ramipril on myocardial tissue properties and heart function, performing CMR and myocardial Ultrasound Tissue Characterisation analysis.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-06
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | — | — |
| Subject | Ramipril | Small molecule | — | — |